Trial Profile
A Phase I Clinical Trial of MRX-4TZT for spastic paralysis.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Tizanidine (Primary)
- Indications Spastic paralysis
- Focus Adverse reactions
- 10 May 2017 New trial record